Logo: to the web site of Uppsala University

uu.sePublications from Uppsala University
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Myocardial External Efficiency in Asymptomatic Severe Primary Mitral Regurgitation Using 11C-Acetate PET
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Surgical Sciences, Radiology.ORCID iD: 0000-0001-5738-9983
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Medical Sciences, Clinical Physiology. Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Medical Sciences, Cardiology.ORCID iD: 0000-0002-6837-3386
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Disciplinary Domain of Medicine and Pharmacy, research centers etc., Uppsala Clinical Research Center (UCR). Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Medical Sciences, Cardiology. Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Medical Sciences, Clinical Physiology.ORCID iD: 0000-0002-8290-557x
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Medical Sciences, Cardiology. Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Medical Sciences, Clinical Physiology.
Show others and affiliations
2023 (English)In: Journal of Nuclear Medicine, ISSN 0161-5505, E-ISSN 1535-5667, Vol. 64, no 4, p. 645-651, article id jnumed.122.264945Article in journal (Refereed) Published
Abstract [en]

Subjects with asymptomatic moderate-severe or severe primary mitral regurgitation (MR) are closely observed for signs of progression or symptoms requiring surgical intervention. The role of myocardial metabolic function in progression of MR is poorly understood. We used 11C-acetate positron emission tomography (PET) to non-invasively measure myocardial external efficiency (MEE), which is the energetic ratio of external cardiac work and left ventricular oxygen consumption.

Methods and Results: 47 patients in surveillance with MR and no or minimal symptoms prospectively underwent PET, echocardiography and cardiac magnetic resonance imaging (CMR) on the same day. PET was used to simultaneously measure cardiac output, LV mass and oxygen consumption to establish MEE. PET in patients were compared to healthy volunteers (n = 9). MEE and standard imaging indicators of regurgitation severity, LV volumes and function were studied as predictors of time to surgical intervention. Patients were followed median 3.0 years (interquartile range 2.0-3.8) and the endpoint was reached in 22 subjects (47%). MEE in patients reaching the endpoint (23.8±5.0%) was lower than in censored patients (28.5±4.5%, P = 0.002) and in healthy volunteers (30.1±4.9%, 0.001). MEE with a cut-off lower than 25.7% was significantly associated with the outcome (hazard ratio of 7.5 (95%CI: 2.7-20.6, p<0.0001) and retained independent significance when compared to standard imaging parameters.

Conclusion: MEE independently predicted time to progression requiring valve surgery in patients with asymptomatic moderate-severe or severe primary MR. The study suggests that inefficient myocardial oxidative metabolism precedes clinically observed progression in MR.

Place, publisher, year, edition, pages
Society of Nuclear Medicine , 2023. Vol. 64, no 4, p. 645-651, article id jnumed.122.264945
Keywords [en]
myocardial efficiency, efficiencymitral regurgitation, cardiovascular MR, PET
National Category
Cardiology and Cardiovascular Disease Radiology, Nuclear Medicine and Medical Imaging
Identifiers
URN: urn:nbn:se:uu:diva-492882DOI: 10.2967/jnumed.122.264945ISI: 000994027400026PubMedID: 36604185OAI: oai:DiVA.org:uu-492882DiVA, id: diva2:1725353
Funder
Swedish Heart Lung Foundation, 20130631Swedish Heart Lung Foundation, 20190593Available from: 2023-01-10 Created: 2023-01-10 Last updated: 2026-02-26Bibliographically approved
In thesis
1. Multimodality evaluation of valvular regurgitation
Open this publication in new window or tab >>Multimodality evaluation of valvular regurgitation
2026 (English)Doctoral thesis, comprehensive summary (Other academic)
Abstract [en]

Background:

Risk stratification in chronic valvular regurgitation remains challenging. In carcinoid heart disease (CaHD), optimal surgical strategy and prognostic determinants are incompletely defined. In asymptomatic severe primary mitral regurgitation (PMR), current guideline thresholds based on left ventricular ejection fraction and end-systolic diameter may fail to detect early myocardial dysfunction. This thesis aimed to refine risk stratification using multimodality imaging and functional assessment.

Methods and Results:

Paper I analysed 60 consecutive patients undergoing valve surgery for CaHD (1986–2019). Thirty-day mortality was 12% overall (8% in the last decade). Combined tricuspid and pulmonary valve replacement (TVR+PVR) was associated with longer survival compared with isolated TVR. Echocardiographic (TTE) assessment of the pulmonary valve was challenging and may underestimate disease severity. NT-proBNP and 5-HIAA independently predicted outcome. Bioprosthetic valve durability was satisfactory.

Papers II–IV prospectively evaluated patients with asymptomatic severe PMR. In Paper II (n=47), myocardial external efficiency (MEE) assessed by 11C-acetate PET was reduced in proportion to regurgitation severity and independently associated with subsequent mitral valve surgery during follow-up. In Paper III (n=48), impaired ventilatory efficiency assessed by cardiopulmonary exercise testing (CPET)—particularly an elevated VE/VCO2 ratio at the anaerobic threshold—independently predicted mitral valve surgery beyond peak VO2 and guideline-based echocardiographic thresholds. In Paper IV (n=49), comprehensive baseline imaging with TTE and cardiovascular magnetic resonance (CMR) demonstrated that volumetric parameters, especially indexed left ventricular end-diastolic volume (LVEDVi), were associated with outcome. In contrast, short-term (1-year) serial changes provided limited additional prognostic value. CMR-derived myocardial extracellular volume and histologically quantified myocardial fibrosis from perioperative biopsies were low or only mildly increased, suggesting limited irreversible myocardial injury at the time of surgery.

Conclusions:

In CaHD, valve surgery was associated with acceptable perioperative risk and prolonged survival, and combined TVR+PVR may be advantageous. Pulmonary valve disease may be underestimated by TTE, supporting the use of complementary imaging when needed. In asymptomatic severe PMR, MEE, ventilatory efficiency, and comprehensive baseline volumetric imaging may provide incremental prognostic information beyond conventional parameters. These findings support a multimodality approach to improve risk stratification and timing of intervention.

Place, publisher, year, edition, pages
Uppsala: Acta Universitatis Upsaliensis, 2026. p. 70
Series
Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine, ISSN 1651-6206 ; 2237
Keywords
Carcinoid heart disease; Primary mitral regurgitation; Echocardiography; Cardiovascular magnetic resonance; Positron emission tomography; Cardiopulmonary exercise testing; Myocardial fibrosis; Risk stratification.
National Category
Cardiology and Cardiovascular Disease
Research subject
Medical Science
Identifiers
urn:nbn:se:uu:diva-580559 (URN)978-91-513-2756-3 (ISBN)
Public defence
2026-04-16, H:son Holmdahlsalen, Entrance 100, Akademiska sjukhuset, Uppsala, 09:15 (Swedish)
Opponent
Supervisors
Available from: 2026-03-25 Created: 2026-02-26 Last updated: 2026-03-25

Open Access in DiVA

No full text in DiVA

Other links

Publisher's full textPubMed

Authority records

Sörensen, JensBergsten, JohannesBaron, TomaszÖrndahl, Lovisa HolmKero, TanjaBjerner, TomasHedin, Eva-MariaHarms, Hendrik J.Flachskampf, Frank

Search in DiVA

By author/editor
Sörensen, JensBergsten, JohannesBaron, TomaszÖrndahl, Lovisa HolmKero, TanjaBjerner, TomasHedin, Eva-MariaHarms, Hendrik J.Flachskampf, Frank
By organisation
RadiologyClinical PhysiologyCardiologyUppsala Clinical Research Center (UCR)Thoracic Surgery
In the same journal
Journal of Nuclear Medicine
Cardiology and Cardiovascular DiseaseRadiology, Nuclear Medicine and Medical Imaging

Search outside of DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 151 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf